Associated Papers
Baseline mutational profiles of patients with carcinoma of unknown primary origin enrolled in the CUPISCO study.
Westphalen CB et al.
Esmo Open, 2023
37922692 (PubMed )
Supplement: mmc1.docx
Landscape of Genetic Mutations in Appendiceal Cancers.
Constantin M et al.
Cancers, 2023
Characterization of KRAS Mutation Subtypes in Non-small Cell Lung Cancer.
Judd J et al.
Molecular Cancer Therapeutics, 2021
Targeted Sequencing of Pancreatic Adenocarcinomas from Patients with Metachronous Pulmonary Metastases.
Hlavac V et al.
Genes, 2020
33255265 (PubMed )
Supplement: genes-11-01391-s001.zip › Hlavac_et_al_Supplementary_Tables_20-11-24SX.xlsx › Supplementary_Table_S4
Lysine Demethylase KDM6A in Differentiation, Development, and Cancer.
Tran N et al.
Molecular and Cellular Biology, 2020
Clinical and Molecular Characteristics of NF1-Mutant Lung Cancer.
Redig AJ et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2016
Comprehensive genomic profiling of 295 cases of clinically advanced urothelial carcinoma of the urinary bladder reveals a high frequency of clinically relevant genomic alterations.
Ross JS et al.
Cancer, 2016
Regulation of Drosophila metamorphosis by xenobiotic response regulators.
Deng H et al.
Plos Genetics, 2013
Somatic p16(INK4a) loss accelerates melanomagenesis.
Monahan KB et al.
Oncogene, 2010
Somatic alterations in the melanoma genome: a high-resolution array-based comparative genomic hybridization study.
Gast A et al.
Genes, Chromosomes & Cancer, 2010
PDGFRA, PDGFRB, EGFR, and downstream signaling activation in malignant peripheral nerve sheath tumor.
Perrone F et al.
Neuro-oncology, 2009
Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study.
Gylling A et al.
Gut, 2007
Genomic Characterization of Low- and High-Grade Pancreatic Mucinous Cystic Neoplasms Reveals Recurrent KRAS Alterations in "High-Risk" Lesions.
Conner JR et al.
Pancreas, 0
Select a paper to view details